Aldeyra Therapeutics Inc (NASDAQ:ALDX)

11.01
Delayed Data
As of Apr 20
 +0.12 / +1.10%
Today’s Change
2.50
Today|||52-Week Range
14.62
+60.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization18.8K35.8K37.8K71.0K
 
 
 
 
 
 
Operating ExpensesGross Income-18.8K-35.8K-37.8K-71.0K
 
 
 
 
 
General Expenses12.0M18.7M22.5M39.6M
 
 
 
 
 
Research And Development7.6M13.2M16.3M29.8M
 
 
 
 
 
Total Operating Expenses12.0M18.7M22.5M39.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.0M-18.7M-22.5M-39.7M
 
 
 
 
 
Interest Expense On Debt112.3K105.5K113.5K146.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.1M-18.7M-22.3M-38.9M
 
 
 
 
 
Net Income-12.1M-18.7M-22.3M-38.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.6M11.4M15.9M21.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.6M11.4M15.9M21.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.40-$1.65-$1.40-$1.79
 
 
 
 
 
EPS Diluted-$1.40-$1.65-$1.40-$1.79